Prothena Reports First Quarter Financial Results
5/15/2013 9:34:07 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DUBLIN, Ireland, May 14, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc. (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases, today reported financial results for the first quarter ended March 31, 2013 and provided an update on research and development.
Help employers find you! Check out all the jobs and post your resume.